Advertisement
Screener

Freshworks Inc. (FRSH) Spending and interest coverage

Freshworks Inc. (FRSH) Spending and interest coverage

  • R&D / revenue · 12 months: Value 19.51%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 14.12%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months19.51%Research and development expense / revenue. Period ending 2026-06-30.

$176.34M ÷ $903.87M × 100 ≈ 19.51%

Stock-based compensation / revenue · 12 months14.12%Share-based compensation / revenue. Period ending 2026-06-30.

$127.64M ÷ $903.87M × 100 ≈ 14.12%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending176.34M USDResearch and Development Expense
Revenue903.87M USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation127.64M USDShare-based Payment Arrangement, Noncash Expense
Operating income30.28M USDOperating Income (Loss)
Interest expense · reported / estimated(m) · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30$176.34M$903.87M$127.64M$30.28M(m)19.51%14.12%(m)(m)
2026-03-31$172.47M$871.17M$139.08M$15.56M(m)19.80%15.96%(m)(m)
2025-12-31$163.21M$838.81M$146.82M$13.21M(m)19.46%17.50%(m)(m)
2025-09-30$162.43M$810.64M$199.89M$-50.32M(m)20.04%24.66%(m)(m)
2025-06-30$168.86M$782.10M$210.07M$-81.73M(m)21.59%26.86%(m)(m)
2025-03-31$169.91M$751.55M$215.93M$-116.86M(m)22.61%28.73%(m)(m)
2024-12-31$164.59M$720.42M$216.71M$-138.61M(m)22.85%30.08%(m)(m)
2024-09-30$159.40M$685.96M$216.93M$-154.86M(m)23.24%31.62%(m)(m)
2024-06-30$146.40M$652.93M$213.35M$-154.73M(m)22.42%32.67%(m)(m)
2024-03-31$139.58M$623.88M$212.46M$-154.23M(m)22.37%34.05%(m)(m)
2023-12-31$137.76M$596.43M$210.71M$-170.17M(m)23.10%35.33%(m)(m)
2023-09-30$136.58M$569.49M$217.11M$-190.74M(m)23.98%38.12%(m)(m)
2023-06-30$137.57M$544.70M$215.88M$-210.29M(m)25.26%39.63%(m)(m)
2023-03-31$137.68M$521.05M$211.76M$-234.35M(m)26.42%40.64%(m)(m)
2022-12-31$135.54M$498.00M$207.70M$-233.37M(m)27.22%41.71%(m)(m)
2022-09-30$129.91M$470.31M$199.84M$-229.14M(m)27.62%42.49%(m)(m)
2022-06-30$151.13M$438.16M$270.20M$-311.10M(m)34.49%61.67%(m)(m)
2022-03-31$135.73M$405.07M$220.07M$-250.19M(m)33.51%54.33%(m)(m)
2021-12-31$120.41M$371.02M$173.44M$-204.78M(m)32.45%46.75%(m)(m)
2021-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31$69.21M$249.66M$43.28M$-56.11M(m)27.72%17.34%(m)(m)
2020-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31$38.56M$172.38M$273.00K$-29.67M(m)22.37%0.16%(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.